HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alpha Hydrox

This article was originally published in The Rose Sheet

Executive Summary

Retinol Night ResQ Optimum Series, an anti-wrinkle firming complex, will be supported with a $3.5 mil. TV campaign beginning in September, Denver-based Neoteric said. The 30- second spots are tagged: "You'll notice the difference; It's night and day." Night ResQ uses Advanced Polymer Systems' Microsponge technology to stabilize vitamin A ("The Rose Sheet" June 15, In Brief). A 1.05 oz tube will retail for about $11.99. Neoteric expects $12 mil. in first-year sales and anticipates distribution in more than 30,000 mass market doors. Alpha Hydrox Vanishing Blemish Solution will ship in August. The 2% salicylic acid formula with oil-free conditioners and natural extracts treats flare-ups without the "dryness, irritation and redness associated with most acne medications," the company claims. Projected first-year sales for the adult-targeted product are $5 mil. A .5 oz white bottle will cost about $7.99...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005594

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel